Study evaluates tools for assessing atrial fibrillation bleeding risk

09/19/2013 | Healio

The HAS-BLED bleeding risk score may be superior to two other scores in predicting major bleeding in patients with atrial fibrillation who have been treated with anticoagulants, according to a study in the Journal of the American College of Cardiology. However, researchers stressed that HAS-BLED was not meant to forecast thromboembolitic events, and they noted that providers should use the CHADS2 and CHA2DS2-VASc scores for that.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN